Answers are grounded in this paper and cite their sources.
Tissue injury is a pervasive feature of human disease, yet adult mammals exhibit limited regenerative capacity. A central determinant of regenerative outcomes is the inflammatory response, which orchestrates tissue repair through mechanisms that are evolutionarily conserved from Drosophila to mammals. Following injury, inflammation drives debris clearance, promotes the release of cytokines and growth factors, and contributes to the restoration of functional cells. However, dysregulated or unresolved inflammation can impair healing, drive scar formation, and ultimately result in organ dysfunction or failure. Here, we focus on recent advances in the spatiotemporal regulation of inflammation during tissue repair that have reshaped our understanding of its underlying mechanisms. We synthesize findings on the dynamic progression of repair from inflammatory initiation to active resolution and stem cell activation, highlighting features of immune cell plasticity and heterogeneity within injury-specific microenvironments, as well as the existence of pivotal macrophage–fibroblast interactions. Furthermore, we delineate the pleiotropic and context-dependent roles of key cytokines and signaling pathways in coordinating these processes. Finally, we discuss current and emerging therapeutic strategies, emphasizing the paradigm shift from broad immunosuppression toward precise modulation of inflammatory networks to promote regeneration and prevent fibrosis. Future progress hinges on integrating multiomic spatial atlases, precision immunomodulation, and standardized therapeutic protocols to decipher and manipulate immune–regenerative crosstalk, thereby driving the development of next-generation regenerative therapies.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: